{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:20:33Z","timestamp":1785532833637,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijrobp.2025.03.011","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:37:20Z","timestamp":1741955840000},"page":"1207-1216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal Lymphomas"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-0747","authenticated-orcid":false,"given":"Krystel","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongryul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ok","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong In","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Kyung","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senzo","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian R.","family":"Gunther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouthaina","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea C.","family":"Pinnix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon S.","family":"Imber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Elsayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans T.","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rabinovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. George","family":"Mikhaeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim M.","family":"Illidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"MacManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Bressel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.03.011_bib0001","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","article-title":"Occurrence and prognosis of extranodal lymphomas","volume":"29","author":"Freeman","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","article-title":"Clinicopathologic analysis of ocular adnexal lymphomas: Extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients","volume":"73","author":"Cho","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0003","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: Clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0004","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","article-title":"Orbital marginal zone B-cell lymphoma of MALT: Radiotherapy results and clinical behavior","volume":"65","author":"Suh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jjco\/hym031","article-title":"Primary ocular adnexal MALT lymphoma: A long-term follow-up study of 114 patients","volume":"37","author":"Tanimoto","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the international lymphoma radiation oncology group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0008","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood-2016-05-714584","article-title":"Long-term course of patients with primary ocular adnexal MALT lymphoma: A large single-institution cohort study","volume":"129","author":"Desai","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10428194.2012.717279","article-title":"Low dose radiotherapy in the marginal zone lymphoma: Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma","volume":"54","author":"Tran","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijrobp.2019.10.029","article-title":"Making every single gray count: Involved site radiation therapy delineation guidelines for hematological malignancies","volume":"106","author":"Dabaja","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0012","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0360-3016(93)90173-S","article-title":"Radiotherapy is successful treatment for orbital lymphoma","volume":"26","author":"Smitt","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0013","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.clon.2022.01.042","article-title":"Treatment outcomes of low-grade lymphoma of the orbit","volume":"34","author":"Holloway","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0014","unstructured":"N.C. Institute Common Toxicity Criteria, version 5.0. 2017.https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf. Last accessed October 22, 2024."},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0015","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.ophtha.2013.02.003","article-title":"Ocular adnexal lymphoma: Assessment of a tumor-node-metastasis staging system","volume":"120","author":"Aronow","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ophtha.2017.05.037","article-title":"Treatments for ocular adnexal lymphoma a report by the American Academy of Ophthalmology","volume":"125","author":"Yen","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0017","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/01676830.2013.842257","article-title":"Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphoma","volume":"33","author":"Rath","year":"2014","journal-title":"Orbit"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0018","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: A rare cancer network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.12701\/yujm.2021.01263","article-title":"Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a narrative review","volume":"39","author":"Chung","year":"2022","journal-title":"J Yeungnam Med Sci"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.eye.6700379","article-title":"Clinical features associated with survival of patients with lymphoma of the ocular adnexa","volume":"17","author":"Jenkins","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0021","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1182\/blood-2018-99-118364","article-title":"Prognostic value of the novel mucosal associated lymphoid tissue prognostic index (MALT-IPI) in marginal zone lymphoma (MZL) cases","volume":"132","author":"Chan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0022","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/cancers14174274","article-title":"Prospective study of 4 Gy radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma (FORMAL)","volume":"14","author":"Park","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0023","first-page":"501","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Lossos","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0024","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/cam4.5092","article-title":"Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort study","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.769530","article-title":"Long-term clinical outcomes in treatment-na\u00efve patients with orbital adnexal mucosa-associated lymphoid tissue lymphoma: A single-center study","volume":"12","author":"Min","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0026","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","article-title":"Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: Efficacy and toxicity","volume":"81","author":"Goda","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12308-020-00424-6","article-title":"Ocular adnexal lymphoma: Long-term outcome, patterns of failure and prognostic factors in 174 patients","volume":"14","author":"Ferry","year":"2021","journal-title":"J Hematop"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0028","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2013.11.235","article-title":"Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: A long-term outcome in 86 patients with 104 treated eyes","volume":"88","author":"Harada","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0029","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.81993","article-title":"Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: Retrospective single institution review of 95 patients","volume":"59","author":"Lim","year":"2011","journal-title":"Indian J Opthalmol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2008.09.011","article-title":"Prognostic significance of anatomic subsites: Results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma","volume":"90","author":"Nam","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0031","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ijrobp.2005.03.005","article-title":"Radiation therapy for orbital lymphoma","volume":"63","author":"Zhou","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0032","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s00277-018-3387-5","article-title":"Treating synchronous bilateral ocular adnexal marginal zone lymphoma: The consortium for improving survival of lymphoma study","volume":"97","author":"Oh","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0033","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","article-title":"Ocular adnexal lymphoma: A review of clinicopathologic features and treatment options","volume":"108","author":"Decaudin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0034","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.5858\/133.8.1262","article-title":"A TNM-based clinical staging system of ocular adnexal lymphomas","volume":"133","author":"Couplan","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue orginating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0036","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ejh.14306","article-title":"Efficacy and safety of frontline single-agent rituximab in extranodal marginal zone lymphoma","volume":"114","author":"Mazzoni","year":"2025","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0037","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMra2102568","article-title":"Marginal-zone lymphomas","volume":"386","author":"Rossi","year":"2022","journal-title":"NEJM"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0038","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2018.11.002","article-title":"Orbital lymphoma-An international multicenter retrospective study","volume":"199","author":"Olsen","year":"2019","journal-title":"Am J Opthalmol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0039","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","article-title":"4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): Long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Hoskin","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0040","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","article-title":"Low-dose radiation therapy (2 Gy \u00d7 2) in the treatment of orbital lymphoma","volume":"86","author":"Fasola","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0041","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/bloodadvances.2021004939","article-title":"Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: Is 4 Gy suitable for curable patients?","volume":"5","author":"Imber","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0042","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2022.07.2322","article-title":"Response adapted ultra low dose radiation therapy for the definitive management of orbital indolent B-cell lymphoma","volume":"114","author":"Pinnix","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.011_bib0043","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:26:40Z","timestamp":1752643600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162500241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S036030162500241X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.011","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal Lymphomas","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}